Edison

Transcript

Edison first set out to develop drugs for inherited mitochondrial dysfunction, where there's a very severe defect in electron flow. As we were working with these cells, and addressing other diseases, what we found, surprisingly, is that many different diseases that are often associated with aging, such as Huntington's disease, have very similar deficiencies in electron flow, and therefore we've been able to utilize the knowledge that we've gained from developing the drugs for the inherited mitochondrial dysfunctions, to address these other diseases of human aging.